Venture CapitalBeyond Capital Ventures
StagesSeed, Pre-Series A
SectorsFintech, Consumer / D2C, Healthcare / Medtech · Early-stage builders, Founder-led / operator capital
Ticket$250K – $2M
Venture CapitalIndia-focused healthcare and wellness fund investing exclusively in scalable companies with validated product-market fit, governance-aligned leadership and a clear pathway to institutional scale; sector specialisation plus long-term partnership capital.
Key signals founders use to decide if this investor is worth a conversation.
Stages and sectors this investor typically backs.
Themes this investor is mapped to across the VC Dekho directory.
India-focused healthcare and wellness fund investing exclusively in scalable companies with validated product-market fit, governance-aligned leadership and a clear pathway to institutional scale; sector specialisation plus long-term partnership capital.
22 companies mapped to this fund.
Background and context for founders evaluating this investor.
Alkemi Growth Capital is a New Delhi-based, early-growth venture fund focused exclusively on India's healthcare and consumer-wellness sectors, founded in 2017 by Alka Goel, who returned from the US to launch one of the few women-led venture funds in the country. Alongside partner Dr. Mansi Aggarwal and a team drawn from McKinsey, IIM-Ahmedabad and AIIMS, Goel has built Alkemi into a sector-specialist investor backing scalable companies that have validated product-market fit, governance-aligned leadership and a clear pathway to institutional scale. The firm's debut fund holds roughly $34 million in assets and has made around 20 investments, primarily at Series A, with cheque sizes spanning $100K to $5 million and a sweet spot near $1.5 million. It is now raising a second fund targeting $75 million, having reached a first close of about $49.7 million with the IFC committing up to $10 million in equity plus a co-investment envelope — a strong endorsement of its strategy and ESG framework. Portfolio companies include diagnostics chain Redcliffe Labs, healthy-snacking brand Farmley, healthcare-staffing platform Jobizo and Akiva Superfoods, with an exit in Doxper. Alkemi's advisory board features senior healthcare and business leaders, including the CEOs of Medanta, Cipla and Swiggy, reinforcing its operator and clinical network.
Alongside partner Dr.
New Delhi. Founded 2017 by Alka Goel (Founder & Managing Partner; Delhi/New York) with Dr. Mansi Aggarwal (Partner); one of few women-led India VCs. Fund I ~$34M AUM, ~20–24 investments. Fund II target $75M (first close $49.7M; IFC up to $10M equity). Portfolio: Redcliffe Labs, Farmley, Jobizo, Akiva Superfoods; exit: Doxper. Healthcare advisory board incl. CEOs of Medanta, Cipla, Swiggy.
Data confidence: Verified (web sources, 2025–26)
Partners and principals mapped to this fund in the directory.
Other funds that overlap on stage, sector, or thesis.
Jump into stage, sector, and thesis mapped to this fund.